Mathew Blackman
Stock Analyst at Stifel
(3.67)
# 729
Out of 4,900 analysts
61
Total ratings
48.84%
Success rate
9.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $6.55 | +6.87% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $15.20 | +103.95% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $236.41 | +34.51% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $11.15 | +124.22% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $12.53 | +99.52% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $289.99 | +1.04% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $55.87 | +68.25% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $10.76 | +123.05% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.35 | +122.22% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $84.78 | +17.95% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $10.71 | +49.39% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $8.93 | +23.18% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $6.55
Upside: +6.87%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $15.20
Upside: +103.95%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $236.41
Upside: +34.51%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $11.15
Upside: +124.22%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $12.53
Upside: +99.52%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $289.99
Upside: +1.04%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $55.87
Upside: +68.25%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $10.76
Upside: +123.05%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.35
Upside: +122.22%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $84.78
Upside: +17.95%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $10.71
Upside: +49.39%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $8.93
Upside: +23.18%